Organogenesis Holdings (ORGO) Income from Continuing Operations (2016 - 2026)

Organogenesis Holdings' Income from Continuing Operations history runs 11 years deep, the most recent figure standing at 53156000.0 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 182.1% year-over-year to 53156000.0; the TTM figure through Mar 2026 stood at 12219000.0 (up 176.94% YoY), while the FY2025 annual figure was 46532000.0, up 5304.41% from the prior year.
• Income from Continuing Operations was 53156000.0 for Q1 2026 at Organogenesis Holdings, down from 53200000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 53200000.0 in Q4 2025 to a low of 53156000.0 in Q1 2026.
• Historically, Income from Continuing Operations has averaged 865588.24 across 5 years, with a median of 215000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations surged 1450.88% in 2024, then plunged 797.29% in 2025.
• A 5-year view of Income from Continuing Operations shows it stood at 7486000.0 in 2022, then tumbled by 107.59% to 568000.0 in 2023, then soared by 1450.88% to 7673000.0 in 2024, then surged by 593.34% to 53200000.0 in 2025, then plunged by 199.92% to 53156000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 53156000.0 (Q1 2026), 53200000.0 (Q4 2025), and 21567000.0 (Q3 2025), per Business Quant data.